Over the past few days, we have examined a recent oversight committee hearing held by the U.S. House of Representatives through its Committee on Judiciary. Specifically, the Subcommittee on the Constitution and Civil Justice elicited testimony from several experts in the field of ethics and whistleblower laws, including several opinions […]
In yesterday’s post, we discussed the recent oversight hearing conducted by the U.S. House of Representatives through its Committee on Judiciary. The hearing, which took place at the end of July, was called in order to address the effectiveness of the False Claims Act, areas ripe for improvement, and issues […]
Late last month, Congress convened a panel of experts in its first False Claims Act oversight hearing in nearly six years. The purpose of the hearing, which was called by the Committee on Judiciary through its Subcommittee on the Constitution and Civil Justice, was to enlist the opinions of several […]
In a recent False Claims Act settlement, Minneapolis-based Vascular Solutions, Inc. (“VSI”) has agreed to pay $520,000 to the federal government in order to settle claims it unlawfully marketed its products for the treatment of varicose veins. The company, which has admitted no liability or guilt in the matter, agreed […]
As you likely know, federal whistleblower laws are designed to protect relators from backlash or adverse employment decisions based solely on the whistleblower’s decision to come forward. Known as anti-retaliation laws, employees who opt to file a whistleblower lawsuit under the False Claims Act may also advance a separate cause […]